Want to see SBC full AI Analyst Report?
SBC Stock Chart & Stats
$4.25
$0.13(4.25%)
At close: 4:00 PM EDT
$4.25
$0.13(4.25%)
Day’s Range― - ―
52-Week Range$2.78 - $5.29
Previous Close$3.19
Volume85.85K
Average Volume (3M)202.17K
Market Cap
$497.78M
Enterprise Value$195.63
Total Cash (Recent Filing)$184.62M
Total Debt (Recent Filing)$48.23M
Price to Earnings (P/E)10.5
Beta0.42
Next Earnings
Nov 12, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.47
Shares Outstanding102,846,950
10 Day Avg. Volume258,870
30 Day Avg. Volume202,167
Financial Highlights & Ratios
PEG Ratio2.07
Price to Book (P/B)1.79
Price to Sales (P/S)2.56
P/FCF Ratio12.15
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$8.50Price Target Upside100.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.46
Revenue Forecast (FY)$187.85M
Bulls Say, Bears Say
Bulls Say
High ProfitabilitySBC’s high gross, EBIT, and net margins indicate strong pricing and cost discipline in its clinic and services model. Sustained profitability provides resources to fund network expansion, technology investment, and diversification while helping the company absorb operating volatility.
Operational GrowthRecent growth is supported by both scale and improving operating leverage: the clinic network expanded while EBITDA grew substantially faster than revenue. That combination suggests stronger productivity and creates a broader platform for recurring patient demand and future service expansion.
Balance Sheet FlexibilityVery low leverage gives SBC financial flexibility to invest in clinics, AI initiatives, international partnerships, and carefully selected acquisitions without relying heavily on additional borrowing. A lightly leveraged balance sheet also improves resilience if elective-care demand becomes uneven.
Bears Say
Revenue VolatilityThe 2025 revenue decline followed by a sharp TTM rebound shows that SBC’s growth has not yet been consistently repeatable. Uneven demand makes forecasting and resource planning more difficult and raises the risk that recent acceleration may not persist across future reporting periods.
Aesthetic ConcentrationSBC remains heavily dependent on aesthetic procedures, leaving its revenue mix exposed to changes in consumer demand and competitive intensity within one category. Management’s diversification initiatives may reduce this reliance, but non-aesthetic services are currently too small to offset that concentration.
Governance ComplianceThe independent-director and audit-committee shortfall creates an ongoing governance execution issue that must be resolved within the Nasdaq cure period. Until corrected, management attention may be diverted and investors face added uncertainty around oversight, controls, and board effectiveness.
SBC FAQ
What was SBC Medical Group Holdings’s price range in the past 12 months?
SBC Medical Group Holdings lowest stock price was $2.78 and its highest was $5.29 in the past 12 months.
What is SBC Medical Group Holdings’s market cap?
SBC Medical Group Holdings’s market cap is $497.78M.
When is SBC Medical Group Holdings’s upcoming earnings report date?
SBC Medical Group Holdings’s upcoming earnings report date is Nov 12, 2026 which is in 41 days.
How were SBC Medical Group Holdings’s earnings last quarter?
SBC Medical Group Holdings released its earnings results on Aug 13, 2026. The company reported $0.1 earnings per share for the quarter, missing the consensus estimate of $0.116 by -$0.016.
Is SBC Medical Group Holdings overvalued?
According to Wall Street analysts SBC Medical Group Holdings’s price is currently Undervalued.
Does SBC Medical Group Holdings pay dividends?
SBC Medical Group Holdings does not currently pay dividends.
What is SBC Medical Group Holdings’s EPS estimate?
SBC Medical Group Holdings’s EPS estimate is 0.12.
How many shares outstanding does SBC Medical Group Holdings have?
SBC Medical Group Holdings has 102,846,950 shares outstanding.
What happened to SBC Medical Group Holdings’s price movement after its last earnings report?
SBC Medical Group Holdings reported an EPS of $0.1 in its last earnings report, missing expectations of $0.116. Following the earnings report the stock price went down -0.313%.
Which hedge fund is a major shareholder of SBC Medical Group Holdings?
Currently, no hedge funds are holding shares in SBC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SBC Medical Group Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.50 (100.00% Upside)
$8.50 (100.00% Upside)
Hedge Fund Trend
Decreased
By 200.0K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
13.82%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
28.98%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
SBC Medical Group Holdings
SBC Medical Group Holdings Incorporated provides comprehensive operational support to aesthetic and cosmetic clinics across a global footprint, including Japan, Vietnam, the United States, and other international markets. The company delivers a diverse array of administrative and support functions, such as orchestrating marketing and advertising campaigns, offering extensive human resources solutions including talent acquisition and staff training, and streamlining appointment scheduling for franchisee clinics. Furthermore, SBC Medical Group facilitates real estate arrangements for both employee housing and clinic facility rentals, oversees the design and construction of new clinics, and manages the procurement of essential medical equipment and supplies. Additionally, the firm furnishes IT software solutions. The broad spectrum of aesthetic and reconstructive procedures facilitated by SBC Medical Group's supported clinics encompasses both surgical and non-surgical interventions. These include popular treatments such as breast augmentation, liposuction, and various rejuvenation therapies targeting wrinkles, acne, scars, and signs of aging. The offerings also extend to specialized procedures like laser skin toning, double fold eye surgery, rhinoplasty, hair transplants, laser hair removal, cosmetic dental work, tattoo removal, and advanced eye procedures like LASIK, among others. Established in 2000, SBC Medical Group Holdings Incorporated maintains its headquarters in Irvine, California.
SBC Company Deck
SBC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed multiple strong operational and financial improvements: double-digit revenue growth, a 32% rise in adjusted EBITDA and margin expansion to 41%, network expansion (+34 locations YoY), rising customer metrics, clear multi-brand and AI-driven strategies, and actionable international initiatives. Challenges flagged were manageable in the near term (one-time SG&A items, currency headwind) and longer-term execution risks around AI rollouts, international scaling and diversification away from aesthetic services. On balance, the positives (strong growth, profitability gains, AI and product/brand initiatives, ample capital for disciplined M&A) materially outweigh the noted challenges.View all SBC earnings summariesSBC Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$8.50
▲(100.00% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Cra International
―
Forrester Research
―
Franklin Covey Company
―
Resources Connection
―
Aeries Technology
―
Ownership Overview
82.36% Insiders
0.49% Mutual Funds
1.93% Other Institutional Investors
14.20% Public Companies and
Individual Investors










